a world leader in genomic data management solutions
BC Platforms provides a powerful genomic and clinical data management and analysis platform for personalized medicine, accelerating the translation of insights into clinical practice. Their genomic data discovery platform enables flexible data integration, secure analysis and interpretation of molecular and clinical information. BC Platforms aims to build the world’s leading analytics platform for healthcare and industry and to revolutionize decision making in drug development bringing clinical benefits to patients. The company is headquartered in Zurich.
Why we invested in BC Platforms
We talk about big data in medicine, but today this data is fragmented, hard to access, and unanalysable. BC Platforms has the technology and the means to federate clinical and genomic data. With BC Platforms, precision medicine becomes a reality for healthcare providers, and big data enabled drug development becomes a real tool for pharma industry. Both benefit Debiopharm’s ultimate goal: better care for patients.
Discover how we can help you bring your ambition to life
February 23, 2021
BC Platforms and Genomenon combine forces to improve clinical genomics diagnosis and research
January 27, 2021
BC Platforms provides data backbone for RIKEN and THL to build AI-driven COVID-19 risk prediction tool
December 18, 2020
BC Platforms technology to be used in UK medical research into early lung cancer diagnosis
May 9, 2017
BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development